Dna X (SONM) Shares Outstanding (Diluted Average) (2022 - 2026)

Dna X has reported Shares Outstanding (Diluted Average) for 5 years, with the latest figure at $1.3 million in Q1 2026.

• For the quarter ending Q1 2026, Shares Outstanding (Diluted Average) rose 289.93% year-over-year to $1.3 million; the trailing twelve-month figure through Mar 2026 stood at $1.3 million (up 289.93% YoY), and the FY2025 full-year result was $722689.0, up 175.71% from the prior year.
• Shares Outstanding (Diluted Average) for Q1 2026 stood at $1.3 million, up from $722689.0 in the prior quarter.
• The five-year high for Shares Outstanding (Diluted Average) was $41.1 million in Q1 2023, with the low at $262118.0 in Q4 2024.
• Historically, Shares Outstanding (Diluted Average) has averaged $10.5 million across 5 years, with a median of $4.4 million in 2023.
• Annual changes were most pronounced in 2024 — Shares Outstanding (Diluted Average) tumbled 93.89% — and 2026, when it soared 289.93%.
• Dna X's Shares Outstanding (Diluted Average) stood at $28.9 million in 2022, then plunged by 85.16% to $4.3 million in 2023, then plunged by 93.89% to $262118.0 in 2024, then surged by 175.71% to $722689.0 in 2025, then surged by 75.05% to $1.3 million in 2026.
• The last three Shares Outstanding (Diluted Average) figures came in at $1.3 million (Q1 2026), $722689.0 (Q4 2025), and $984927.0 (Q3 2025), per Business Quant data.